Aurobindo Pharma Limited — Updates, 17-09-2025: General Updates
17-09-2025 | 05:18 pm
17-09-2025 | 05:18 pm
Aurobindo Pharma's subsidiary launched a new wholly-owned unit, Aurobindo Pharma (Malaysia) SDN. BHD., with ~USD 100,000 initial capital. This expands their pharmaceutical business into the Malaysian market, signaling growth intent.
No comments yet. Be the first to comment!
